| Improved outcome of refractory/relapsed acute myeloid leukemia after post-transplantation cyclophosphamide-based haploidentical transplantation with myeloablative conditioning … SR Jaiswal, S Zaman, A Chakrabarti, S Sen, S Mukherjee, S Bhargava, ... Biology of Blood and Marrow Transplantation 22 (10), 1867-1873, 2016 | 66 | 2016 |
| Haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in children with advanced acute leukemia with fludarabine-, busulfan-, and … SR Jaiswal, A Chakrabarti, S Chatterjee, S Bhargava, K Ray, P O'Donnell, ... Biology of Blood and Marrow Transplantation 22 (3), 499-504, 2016 | 66 | 2016 |
| CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt … SR Jaiswal, S Zaman, M Nedunchezhian, A Chakrabarti, P Bhakuni, ... Cytotherapy 19 (4), 531-542, 2017 | 54 | 2017 |
| T cell costimulation blockade promotes transplantation tolerance in combination with sirolimus and post-transplantation cyclophosphamide for haploidentical transplantation in … SR Jaiswal, P Bhakuni, S Zaman, S Bansal, P Bharadwaj, S Bhargava, ... Transplant Immunology 43, 54-59, 2017 | 48 | 2017 |
| Gut colonization with carbapenem-resistant Enterobacteriaceae adversely impacts the outcome in patients with hematological malignancies: results of a prospective surveillance study SR Jaiswal, S Gupta, RS Kumar, A Sherawat, A Rajoreya, SK Dash, ... Mediterranean Journal of Hematology and Infectious Diseases 10 (1), 2018 | 46 | 2018 |
| Pre-transplant sirolimus might improve the outcome of haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide for patients with severe … SR Jaiswal, S Chatterjee, S Mukherjee, K Ray, S Chakrabarti Bone Marrow Transplantation 50 (6), 873-875, 2015 | 33 | 2015 |
| Haploidentical transplantation in children with unmanipulated peripheral blood stem cell graft: The need to look beyond post‐transplantation cyclophosphamide in younger children SR Jaiswal, A Chakrabarti, S Chatterjee, K Ray, S Chakrabarti Pediatric Transplantation 20 (5), 675-682, 2016 | 31 | 2016 |
| Hemophagocytic syndrome following haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide SR Jaiswal, A Chakrabarti, S Chatterjee, S Bhargava, K Ray, ... International journal of hematology 103 (2), 234-242, 2016 | 25 | 2016 |
| CTLA4Ig primed donor lymphocyte infusion: a novel approach to immunotherapy after haploidentical transplantation for advanced leukemia SR Jaiswal, P Bhakuni, A Joy, S Kaushal, A Chakrabarti, S Chakrabarti Biology of Blood and Marrow Transplantation 25 (4), 673-682, 2019 | 24 | 2019 |
| Alterations in NKG2A and NKG2C Subsets of Natural Killer Cells Following Epstein–Barr Virus Reactivation in CTLA4Ig-based Haploidentical Transplantation Is Associated With … SR Jaiswal, P Bhakuni, G Bhagwati, HM Aiyar, A Chakrabarti, ... Transplantation 104 (1), e23-e30, 2020 | 20 | 2020 |
| CTLA4Ig in an extended schedule along with sirolimus improves outcome with a distinct pattern of immune reconstitution following post-transplantation cyclophosphamide-based … SR Jaiswal, P Bhakuni, HM Aiyer, M Soni, S Bansal, S Chakrabarti Biology of Blood and Marrow Transplantation 26 (8), 1469-1476, 2020 | 19 | 2020 |
| T cell costimulation blockade for hyperacute steroid refractory graft versus-host disease in children undergoing haploidentical transplantation SR Jaiswal, S Zaman, A Chakrabarti, A Sehrawat, S Bansal, M Gupta, ... Transplant immunology 39, 46-51, 2016 | 19 | 2016 |
| Higher CD45RA+ Regulatory T Cells in the Graft Improves Outcome in Younger Patients Undergoing T Cell–Replete Haploidentical Transplantation: Where Donor Age Matters SR Jaiswal, P Bhakuni, A Joy, N Murli, A Rajoreya, A Chakrabarti, ... Biology of Blood and Marrow Transplantation 24 (10), 2025-2033, 2018 | 17 | 2018 |
| Impact of extended infusional mesna prophylaxis on the incidence of BK viruria and hemorrhagic cystitis following post-transplantation cyclophosphamide and CTLA4Ig-based … SR Jaiswal, P Singhal, A Thatai, G Bhagwati, HM Aiyer, A Chakrabarti, ... Annals of Hematology 99 (4), 839-845, 2020 | 15 | 2020 |
| Impact of Single-Dose Plerixafor as an Adjunct to Granulocyte Colony-Stimulating Factor–Based Peripheral Blood Stem Cell Mobilization on the Graft Composition and Outcome for T … SR Jaiswal, P Bhakuni, A Joy, N Murli, P Bharadwaj, S Zaman, ... Biology of Blood and Marrow Transplantation 24 (3), 542-548, 2018 | 14 | 2018 |
| Early and sustained expansion of adaptive natural killer cells following haploidentical transplantation and CTLA4Ig-primed donor lymphocyte infusions dissociate graft-versus … SR Jaiswal, S Chakraborty, R Lakhchaura, P Shashi, A Mehta, M Soni, ... Transplantation and Cellular Therapy 27 (2), 144-151, 2021 | 12 | 2021 |
| Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID‐19 lung disease SR Jaiswal, J Arunachalam, A Bhardwaj, A Saifullah, R Lakhchaura, ... Clinical & Translational Immunology 11 (1), e1359, 2022 | 11 | 2022 |
| Focusing on a unique innate memory cell population of natural killer cells in the fight against COVID-19: harnessing the ubiquity of cytomegalovirus exposure SR Jaiswal, P Malhotra, DK Mitra, S Chakrabarti Mediterranean Journal of Hematology and Infectious Diseases 12 (1), 2020 | 11 | 2020 |
| CTLA4Ig-primed donor lymphocyte infusions following haploidentical transplantation improve outcome with a distinct pattern of early immune reconstitution as compared to … SR Jaiswal, P Bhakuni, G Bhagawati, HM Aiyer, M Soni, N Sharma, ... Bone Marrow Transplantation 56 (1), 185-194, 2021 | 10 | 2021 |
| CTLA4Ig-based reduced intensity conditioning and donor lymphocyte infusions for haploidentical transplantation in refractory aggressive B-cell lymphoma relapsing after an … SR Jaiswal, HM Aiyer, G Rawat, A Gera, S Chakrabarti Experimental Hematology 77, 26-35. e1, 2019 | 10 | 2019 |
